Scholarlink

<p>Technological advances in medicine now enable wireless antibradycardia myocardial stimulation. Leadless pacemakers (LP) have already been introduced by Abbott (Abbott Park, IL, USA; Nanostim™, Aveir™), Medtronic (Minneapolis, MN, USA; Micra AV/VR™), and most recently by Boston Scientific (Marlborough, MA, USA; EMPOWER™). Although case reports have been published using different LP in combination with the EMBLEM™ S‑ICD, only the EMPOWER™ LP provides the technological prerequisites for modular cardiac rhythm management (mCRM). In this modular system, an ATP command can be transmitted from the S‑ICD to the LP when required, potentially reducing the number of S‑ICD shocks. Additionally, long-term antibradycardia pacing can be reliably ensured. Following extensive preclinical studies, the 6‑month results of the first prospective multicenter study (MODULAR-ATP) are now available, analyzing the safety, performance, and necessity of the mCRM system.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Modulares Herzrhythmusmanagement

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月29日

查看全文
  • Boris Rudic,
  • Daniel Dürschmied,
  • Ibrahim Akin,
  • Jürgen Kuschyk

摘要

Technological advances in medicine now enable wireless antibradycardia myocardial stimulation. Leadless pacemakers (LP) have already been introduced by Abbott (Abbott Park, IL, USA; Nanostim™, Aveir™), Medtronic (Minneapolis, MN, USA; Micra AV/VR™), and most recently by Boston Scientific (Marlborough, MA, USA; EMPOWER™). Although case reports have been published using different LP in combination with the EMBLEM™ S‑ICD, only the EMPOWER™ LP provides the technological prerequisites for modular cardiac rhythm management (mCRM). In this modular system, an ATP command can be transmitted from the S‑ICD to the LP when required, potentially reducing the number of S‑ICD shocks. Additionally, long-term antibradycardia pacing can be reliably ensured. Following extensive preclinical studies, the 6‑month results of the first prospective multicenter study (MODULAR-ATP) are now available, analyzing the safety, performance, and necessity of the mCRM system.